Skip to main content

User account menu

  • Safety Data
  • Package Inserts

Main navigation

  • Women's Health Products
    • Breast Health
    • Gynecological Health
    • Sexual Health
    • Body Composition
    • Skeletal Health
  • Lab Technologies
    • Tests
    • Cytology
    • Molecular Diagnostics
    • Collection Devices
    • Screening Technologies
  • About
    • Hologic Highlights
    • Coronavirus Update
    • Investor Relations
    • Media Library
    • Events
    • Sustainability
    • Global Access Initiative
    • Philanthropy
    • Project Health Equality
    • Hologic Timeline
    • Real Women's Stories
    • Well Woman
    • Locations
  • Support
    • Safety Data Sheets
    • Package Inserts
    • Contact
    • Medical Education
    • Order Online (iStore)
    • Contact our Compliance Hotline
  • Careers
  • Women's Health Index

Second top menu

  • Women's Health Index
  • Investors
  • Careers
  • Contact us
  • Sign in

Site selector

  • Country: USA
    • Canada
    • China
    • France
    • Germany
    • Italy
    • Japan
    • Netherlands

Site selector

  • Country: USA
    • Canada
    • China
    • France
    • Germany
    • Italy
    • Japan
    • Netherlands

User account menu

  • Safety Data
  • Package Inserts

Second top menu

  • Women's Health Index
  • Investors
  • Careers
  • Contact us
  • Sign in
Home

Main navigation (Header)

  • Women's Health Products
    • Breast Health
    • Gynecological Health
    • Sexual Health
    • Body Composition
    • Skeletal Health
  • Lab Technologies
    • Tests
    • Cytology
    • Molecular Diagnostics
    • Collection Devices
    • Screening Technologies
  • About
    • Hologic Highlights
    • Coronavirus Update
    • Investor Relations
    • Media Library
    • Events
    • Sustainability
    • Global Access Initiative
    • Philanthropy
    • Project Health Equality
    • Hologic Timeline
    • Real Women's Stories
    • Well Woman
    • Locations
  • Support
    • Safety Data Sheets
    • Package Inserts
    • Contact
    • Medical Education
    • Order Online (iStore)
    • Contact our Compliance Hotline
  • Careers
  • Women's Health Index
Home
Back to Products

Panther® System

Grow on Panther

Find Support

The foundation for assay consolidation, future scalability and growth

Add the Panther system to your lab and the capability to consolidate menu on a fully automated system, load samples in any order at any time, eliminate batch constraints and decrease turnaround time.

    Labor savings
    • Broad assay menu on a single platform allows consolidation and the ability to run more tests per full-time employee

    • Full automation allows samples to be loaded at the end of the day and run labor free after hours

    • Ability to run multiple test orders from the same patient sample at the same time expedites results

    • Ability to load primary sample tubes eliminates manual transfer of specimen

    Time savings
    • Flexible sample loading provides control over workflow by either random access or batch processing

    • Programmable/automated maintenance allows tasks to run labor free during non-operational hours

    • STAT samples can be loaded at any time, allowing urgent samples to be prioritized

    • Specialized reports to automate tracking and trending of QC and results: Levey-Jennings, Prevalence Reports, Sample History Report, Sample Curve Report and Maintenance Checklist

    • Add on additional IVD menu without disrupting existing workflow

    Cost savings
    • Small footprint gives labs the ability to run more tests per sq ft and options for scalability and redundancy

    • Consolidation of platforms helps reduce LIS connection costs and streamline tech training and competencies

    • Consumables designed to reduce waste (tubes vs plate) and included in price-per-test provide transparency

    • Liquid waste is nonhazardous and does not require special handling*

    • QC only required every 24 hours, or with a new kit, reducing time and costs

    *Follow local and state guidelines

    Consolidate your assay menu

    The Aptima® assays help guide patient care and enable early detection. With a menu and pipeline of world-class assays you can consolidate your molecular testing today and meet your lab’s growing needs tomorrow.

    Placeholder image

    Assays that run on the Panther System

    Women's Health

    CT/NG

    Mycoplasma genitalium

    Trichomonas vaginalis 

    Bacterial vaginosis

    Candida vaginitis/Trichomonas vaginalis

    HSV 1 & 2 

    HPV 

    HPV genotype 16 18/45

    Zika Virus*

    Infectious Disease

    HIV-1 Quant Dx

    HCV Quant

    HBV Quant

    SARS-CoV-2*

    SARS-CoV-2/Flu/A/B/*

    CMV†

    Find Support

    All Other Requests

    * The Aptima SARS-CoV-2, Aptima Zika Virus, Aptima SARS-CoV-2/Flu and Panther Fusion SARS-CoV-2 assays have not been FDA cleared or approved: These tests have been authorized by FDA under an EUA for use by authorized laboratories; The Aptima and Panther Fusion SARS-CoV-2 assays have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; The Aptima Zika Virus assay has been authorized only for the detection of nucleic acid from Zika virus, not for any other viruses or pathogens; The Aptima SARS-CoV-2/Flu assay  has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, influenza B virus, and not for any other viruses or pathogens. The Aptima SARS-CoV-2, Panther Fusion SARS-CoV-2, and Aptima SARS-CoV-2/Flu assays are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. The Aptima Zika assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
    † In Development and not for sale

    Related Products

    Panther Fusion® System

    Panther Fusion® System

    Panther® Plus

    Panther® Plus

    Panther® Link

    Panther® Link

    Panther Trax

    Panther Trax

    Placeholder

    Panther® Scalable Solutions

    Back to Products

    Panther® System

    Grow on Panther

    Find Support

    The foundation for assay consolidation, future scalability and growth

    Add the Panther system to your lab and the capability to consolidate menu on a fully automated system, load samples in any order at any time, eliminate batch constraints and decrease turnaround time.

      Labour savings
      • Broad assay menu on a single platform allows consolidation and the ability to run more tests per full-time employee

      • Full automation allows samples to be loaded at the end of the day and run labour free after hours

      • Ability to run multiple test orders from the same patient sample at the same time expedites results

      • Ability to load primary sample tubes eliminates manual transfer of specimen

      Time savings
      • Flexible sample loading provides control over workflow by either random access or batch processing

      • Programmable/automated maintenance allows tasks to run labour free during non-operational hours

      • STAT samples can be loaded at any time, allowing urgent samples to be prioritized

      • Specialized reports to automate tracking and trending of QC and results: Levey-Jennings, Prevalence Reports, Sample History Report, Sample Curve Report and Maintenance Checklist

      • Add on additional IVD menu without disrupting existing workflow

      Cost savings
      • Small footprint gives labs the ability to run more tests per sq ft and options for scalability and redundancy

      • Consolidation of platforms helps reduce LIS connection costs and streamline tech training and competencies

      • Consumables designed to reduce waste (tubes vs plate) and included in price-per-test provide transparency

      • Liquid waste is nonhazardous and does not require special handling*

      • QC only required every 24 hours, or with a new kit, reducing time and costs

      *Follow local and state guidelines

      Consolidate your assay menu

      The Aptima® assays help guide patient care and enable early detection. With a menu and pipeline of world-class assays you can consolidate your molecular testing today and meet your lab’s growing needs tomorrow.

      Placeholder image

      Assays that run on the Panther System

      Women's Health

      CT/NG

      CT

      NG

      MG

      TV

      BV

      Candida/TV

      HSV 1 & 2 

      HPV 

      HPV genotype 16 18/45

      Zika Virus*

      Infectious Disease

      HIV-1 Quant Dx

      HCV Quant DX

      HBV Quant

      SARS-CoV-2*

      SARS-CoV-2/Flu/A/B*

      CMV†

      Find Support

      All Other Requests

      * The Aptima SARS-CoV-2, Aptima Zika Virus, Aptima SARS-CoV-2/Flu and Panther Fusion SARS-CoV-2 assays have not been FDA cleared or approved: These tests have been authorized by FDA under an EUA for use by authorized laboratories; The Aptima and Panther Fusion SARS-CoV-2 assays have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; The Aptima Zika Virus assay has been authorized only for the detection of nucleic acid from Zika virus, not for any other viruses or pathogens; The Aptima SARS-CoV-2/Flu assay  has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, influenza B virus, and not for any other viruses or pathogens. The Aptima SARS-CoV-2, Panther Fusion SARS-CoV-2, and Aptima SARS-CoV-2/Flu assays are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. The Aptima Zika assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
      † In Development and not for sale

      Related Products

      Panther Fusion® System

      Panther Fusion® System

      Panther® Plus

      Panther® Plus

      Panther® Link

      Panther® Link

      Panther Trax

      Panther Trax

      Placeholder

      Panther® Scalable Solutions

      Main navigation (Footer)

      • Women's Health Products
        • Breast Health
        • Gynecological Health
        • Sexual Health
        • Body Composition
        • Skeletal Health
      • Lab Technologies
        • Tests
        • Cytology
        • Molecular Diagnostics
        • Collection Devices
        • Screening Technologies
      • About
        • Hologic Highlights
        • Coronavirus Update
        • Investor Relations
        • Media Library
        • Events
        • Sustainability
        • Global Access Initiative
        • Philanthropy
        • Project Health Equality
        • Hologic Timeline
        • Real Women's Stories
        • Well Woman
        • Locations
      • Support
        • Safety Data Sheets
        • Package Inserts
        • Contact
        • Medical Education
        • Order Online (iStore)
        • Contact our Compliance Hotline
      • Careers
      • Women's Health Index
      Hologic footer logo

      © Copyright 2022 Hologic, Inc. All rights reserved.

      Health logo

      Footer menu

      • Privacy Policy
      • Terms & Conditions
      • Patent Info
      • AdvaMed Code of Ethics
      • International Modern Slavery Statement

      Footer social links

      • Twitter
      • Linkedin
      • Facebook
      • Glassdoor
      • Youtube
      • Instagram